TORONTO--(BUSINESS WIRE)--CellAegis Devices, Inc., a medical devices company in the clinical testing stages prior to anticipated global market introductions of the Company’s proprietary, automated, noninvasive autoRIC™ Device for Remote Ischemic Conditioning (RIC), announced today the appointment of Sidney Levitsky, M.D., to the Company’s Scientific Advisory Board (SAB). Dr. Levitsky joins a renowned group of advisors who have participated in leading international clinical trial programs to innovate new treatments for angina, myocardial infarction (MI), reperfusion injury and other serious cardiovascular conditions. Dr. Levitsky’s addition brings the number of CellAegis SAB members to six.